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Abstract
Background: Adenoid Cystic Carcinoma (ACC) is a rare tumor entity and comprises about 1%
of all malignant tumor of the oral and maxillofacial region. It is slow growing but a highly invasive
cancer with a high recurrence rate. Intracranial ACC is even more infrequent and could be primary
or secondary occurring either by direct invasion, hematogenous spread, or perineural spread. We
report the first case of the 5th and 6th nerve palsy due to cavernous sinus invasion by adenoid cystic
carcinoma.
Case presentation: A 49-year-old African American female presented to the emergency room
complaining of severe right-sided headache, photophobia, dizziness and nausea, with diplopia. The
patient had a 14 year history migraine headaches, hypertension, and mild intermittent asthma.
Physical examination revealed right lateral rectus muscle palsy with esotropia. There was numbness
in all three divisions of the right trigeminal nerve. Motor and sensory examination of extremities
was normal. An MRI of the brain/brain stem was obtained which showed a large mass in the clivus
extending to involve the nasopharynx, pterygoid plate, sphenoid and right cavernous sinuses.
Biopsy showed an ACC tumor with a cribriform pattern of the minor salivary glands. The patient
underwent total gross surgical resection and radiation therapy.
Conclusion: This is a case of ACC of the minor salivary glands with intracranial invasion. The
patient had long history of headaches which changed in character during the past year, and
symptoms of acute 5th and 6th cranial nerve involvement. Our unique case demonstrates direct
invasion of cavernous sinus and could explain the 5th and 6th cranial nerve involvement as
histopathology revealed no perineural invasion.
Background
Adenoid Cystic Carcinoma (ACC) is a rare tumor entity
and comprises about 1% of all malignant tumor of the
oral and maxillofacial region [1]. It is a slowly growing but
highly invasive cancer with high recurrence rate. Lym-
phatic spread to local lymph nodes is rare. Hematogenous
spread, however, occurs often in the course of the disease
[2]. Intracranial ACC even is more rare and has been
reported as 4 – 22% of ACC [3]. It could be primary or sec-
ondary which could occur either by direct invasion like in
our case, hematogenous spread, or perineural spread
[4,5]. Perineural spread of ACC has long been recognized.
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The literature revealed that the region of Gasserian gan-
glion to be the most common site of involvement
(35.8%) [2,3,6,7], while cavernous sinus was involved in
15.1% [3-5,8,9]. Presenting signs and symptoms are
related to the anatomical site of the lesion. Facial pain,
parasthesia in trigeminal distribution is commonly
reported reflecting the frequency of involvement of gasse-
rian ganglia, and possibility of perineural spread along the
trigeminal nerve. Involvement of cavernous sinus could
be asymptomatic [3] or could present with involvement
of either 3rd, 4th, 5th, 6th and internal carotid artery [8,9].
Literature is consistent that the time between onset of neu-
rological signs and symptoms, and the time of diagnosis
range between few months to 3 years [3,6,7,10]. However,
one study suggests that the duration could be several years
[8].
Case presentation
A 49-year-old African American female with a past medi-
cal history of hypertension, migraine headaches and mild
intermittent asthma presented to emergency room with a
severe right-sided headache for the last 3 days. The patient
gave a 14-year history of migraine headaches described as
a slow onset unilateral throbbing headaches without aura
accompanied by nausea and lasting 2–3 days. The patient
stated that her migraine attacks were decreasing in fre-
quency and severity for the past 2–3 years until the past
year when she started experiencing different kind of head-
ache. At the time of examination, she described the head-
ache as sharp, intermittent, non-radiating pain with
sudden onset behind her right eye lasting 1–2 days. Dur-
ing the last 3 days the pain became more intense, reported
as 10/10 on the pain scale 1 to 10, with associated photo-
phobia, dizziness and nausea, with diplopia that was
worsened with gaze to the right lateral field. Her past med-
ical history was significant for hypertension and asthma
which were stable. Her past surgical history is significant
for adenoidectomy at age of 12. Her family history is sig-
nificant for a sister with breast cancer, and a father who
died of renal cancer. A complete review of systems was
otherwise negative.
On physical examination the patient displayed right lat-
eral rectus muscle palsy (6th cranial nerve palsy) with
inward deviation of her right eye. There was numbness in
all three divisions of the right trigeminal nerve, suggesting
involvement of the fifth cranial nerve. There was no evi-
dence of right 3rd, 4th, 7th or 8th nerve involvement. Motor
and sensory examination of her extremities was normal.
The rest of the examination was negative. The patient was
admitted to the inpatient service. Her pain was controlled
with medications. All laboratory studies, including com-
plete blood count, biochemical studies and syphilis
screening were negative. A Magnetic Resonance Imaging
(MRI) of the brain and brain stem revealed a large mass in
the clivus extending anteriorly, involving the nasopharynx
and sphenoid sinus, and posteriorly destroying the clivus
laying anterior to the pons. There was destruction of the
pterygoid plate and right cavernous sinus (Figure 1). Neu-
rology consult recommended starting the patient on
phenytoin and dexamethasone for seizure prophylaxis. A
pituitary profile was ordered which revealed a slight eleva-
tion of prolactin level 39.1 ng/ml (normal 20 ng/ml). On
day number 2 of admission, neurosurgery and otolaryn-
gology were consulted and the patient underwent sinus
endoscopy with biopsy of the right sphenoid sinus. From
days 3 to 6, the patient was stable, and pain was control-
led. On day 6th pathology revealed a tumor with a cribri-
form pattern. The neoplastic cells were monotonous and
intraluminal basophilic material was noted. No
perineural invasion was identified. The neoplastic cells
were strongly positive for cytokertain AE1/AE3 and posi-
tive for S-100 and CD117. This histology indicated ACC
of the minor salivary glands. Oncology consultant recom-
mended resection followed by radiation. Additional work
up included a thin cut computerized tomography (CT),
which revealed bone invasion. Chest, abdomen and pelvis
CT scans were negative for metastatic disease. The patient
underwent total gross surgical resection. A postoperative
CT scan showed partial resection of the tumor and the
patient was scheduled for a second surgery followed by
postoperative radiation.
Discussion
Our patient's course prior to diagnosis is unusual. The
patient had a history of 14-year headaches which changed
in character for the past year, and symptoms of acute 6th
and 5th cranial nerve involvement. It is difficult to deter-
mine whether the 14-year history of headache was due to
slowly growing ACC with gradual invasion of clivus,
nasopharnx sphenoid, and cavernous sinus. It is possible
that when the patient started experiencing "different"
kind of headache was a warning sign of intracranial inva-
sion of vital structures. This is likely due to the fact that
ACC is a very slowly growing tumor [2,7,8], and the size
of the patient's tumor was 3.8 × 3 × 2 cm. when discov-
ered. In our case, direct invasion of cavernous sinus could
explain 6th and 5th cranial involvement, as histopathology
revealed no perineural invasion. Based on the literature
review, there are only two other cases of intracranial ACC
with 6th nerve involvement. One case was reported 6th
nerve involvement due to perineural spread [6] and sec-
ond case was duo to invasion of the cavernous sinus [9].
The prognostic factors of ACC depend on tumor site,
tumor stage, the presence of perineural invasion, and
tumor grade. Tubular and cribriform subtypes have better
prognosis than solid subtypes [2,11,12]. Many authors
describe worse prognosis for tumor of the minor salivary
glands, due to early local infiltration and invasion of sur-BMC Cancer 2007, 7:157 http://www.biomedcentral.com/1471-2407/7/157
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Magnetic Resonance Imaging of the Brain: a large mass in the clivus extending anteriorly to involve the nasopharynx and sphe- noid sinus and posteriorly to destroy the clivus and lie anterior to the pons Figure 1
Magnetic Resonance Imaging of the Brain: a large mass in the clivus extending anteriorly to involve the nasopharynx and sphe-
noid sinus and posteriorly to destroy the clivus and lie anterior to the pons.Publish with BioMed Central    and   every 
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rounding tissue and bone [13,14] as in our reported case.
The treatment of choice consists of total tumor resection
[1-7,10,11]. However, there is still controversy regarding
the adjuvant treatment of this tumor. Several authors rec-
ommend postoperative radiation since radiation often
produces tumor regression and relieve symptoms [15-17].
Prokopakis and Kokemueller, on the other hand, doubt
that postoperative radiation may influence the course of
the disease [1,18]. On the other hand, chemotherapy use
for ACC is controversial. Some authors report it being
ineffective [9] while others had some positive response
and recommend chemotherapy as palliative treatment in
advance cases of ACC [19].
Conclusion
We report a case of ACC arising from the minor salivary
glands and invading the clivus nasopharynx, sphenoid,
and cavernous sinuses. Controversy exists regarding the
most effective treatment of ACC and there is lack of relia-
ble information about the clinical behavior of ACC in
response to treatment. Further clinical trials needed to
evaluate the effectiveness of treatment on improving qual-
ity of life and survival rates. This case is a reminder that
careful monitoring of headache symptoms in patients is
essential and a change in characteristics should prompt
further investigations.
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